American Society of Hematology

SHERPA: Blue

People

  1. Hassoun
    Hassoun
  2. Giralt
    Giralt
  3. Landau
    Landau
  4. Lesokhin
    Lesokhin
  5. Chung
    Chung
  6. Devlin
    Devlin
  7. Korde
    Korde
  8. Dogan
    Dogan
  9. Flombaum
    Flombaum
  10. Funt
    Funt

Groups

  1. Center for Hematologic Malignancies (15)
  2. Department of Medicine (15)
  3. Hematologic Malignancies Research (15)
  4. Hematologic Malignancies, Division of (15)
  5. Myeloma (15)
  6. Survivorship Research (7)
  7. Bone Marrow Transplant (6)
  8. Biostatistics Service (4)
  9. Epidemiology and Biostatistics (4)
  10. Cardiology (1)
Search Within
  1. "2015"
  2. "Carl Landgren"
Formats
  1. Meeting Abstract (11)
  2. Journal Article (4)
Groups
  1. Center for Hematologic Malignancies (15)
  2. Department of Medicine (15)
  3. Hematologic Malignancies Research (15)
  4. Hematologic Malignancies, Division of (15)
  5. Myeloma (15)
  6. Survivorship Research (7)

More Groups

People
  1. Carl Landgren (15)
  2. Hani Hassoun (7)
  3. Heather Landau (6)
  4. Nikoletta Lendvai (6)
  5. Sergio Giralt (6)
  6. Alexander Lesokhin (5)

More People

Years
  1. 2015 (15)
Publications
  1. Blood (15)

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Success of online curriculum-based education in the management of multiple myeloma and continuing gaps among hematologists/oncologists
    Meeting Abstract

    Van Laar, E. S.; Landgren, O.
    Blood (2015)

    Fulltext@MSK | Save
  • Autologous hematopoietic stem cell transplantation overcomes primary refractory disease in multiple myeloma patients treated with novel agents
    Meeting Abstract

    Shah, G. L.; Hsu, M.; Devlin, S.; Chung, D. J.; Hassoun, H.; Koehne, G.; Korde, N. S.; Lendvai, N.; Lesokhin, A. M.; Landgren, O.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Continuous treatment with lenalidomide plus low-dose dexamethasone (Ld) versus Ld induction followed by autologous stem cell transplant (ASCT) in patients with newly diagnosed multiple myeloma (NDMM): A pooled analysis of two randomized clinical trials
    Meeting Abstract

    Lentzsch, S.; Villanueva, N.; Nguyen, J.; Landau, H.; Lendvai, N.; Miao, S.; Schecter, J. M.; Reyna, M.; Mapara, M. Y.; Redner, R. L.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • No risk of arterial or venous thrombosis in monoclonal gammopathy of undetermined significance: Results from a population-based study
    Meeting Abstract

    Lindqvist, E. K.; Lund, S. H.; Costello, R.; Burton, D.; Korde, N. S.; Mailankody, S.; Gudnason, V.; Eiriksdottir, G.; Launer, L.; Harris, T. B.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Biomarkers of cardiotoxicity among multiple myeloma patients subsequently treated with proteasome inhibitor therapy
    Meeting Abstract

    Lendvai, N.; Devlin, S.; Patel, M.; Knapp, K. M.; Ekman, D.; Grundberg, I.; Chung, D. J.; Hassoun, H.; Koehne, G.; Lesokhin, A. M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Induction with bortezomib and dexamethasone (BD) followed by risk adapted high dose melphalan and autologous stem cell transplantation and BD consolidation in patients with AL amyloidosis: A phase II feasibility study
    Meeting Abstract

    Landau, H.; Montanez, N.; Cowan, A.; Hoover, E.; Flombaum, C.; Liu, J.; Maurer, M.; Lendvai, N.; Landgren, O.; Giralt, S. A.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Incidence and management of proteasome inhibitor-related cardiotoxicity in multiple myeloma patients at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Land, J.; Afifi, S.; Adel, N. G.; Devlin, S.; Arora, A.; Lendvai, N.; Landgren, O.
    Blood (2015)

    Fulltext@MSK | Save
  • The long PD-1 receptor binding kinetics of nivolumab may increase efficacy of subsequent therapy in relapsed and refractory multiple myeloma patients
    Meeting Abstract

    Funt, S. A.; Page, D. B.; Cattry, D.; Lendvai, N.; Hassoun, H.; Landgren, O.; Borrello, I. M.; Lesokhin, A. M.
    Blood (2015)

    Fulltext@MSK | Save
  • A population-based study of incidence of myeloproliferative neoplasms in Sweden between 2000 and 2012
    Meeting Abstract

    Hultcrantz, M.; Andersson, T. M. L.; Landgren, O.; Dickman, P. W.; Andreasson, B.; Bjorkholm, M.; Kristinsson, S. Y.
    Blood (2015)

    Fulltext@MSK | Save
  • The majority of patients with relapsing light chain (AL) amyloidosis are not eligible for enrollment onto clinical trials: Using screen failures to define major unmet medical needs
    Meeting Abstract

    Landau, H.; Comenzo, R. L.; Balasinorwala, T.; Warner, M.; Landgren, O.; Giralt, S. A.; Hassoun, H.
    Blood (2015)

    Fulltext@MSK | Save